Paris - January 26, 2024
8:30
Welcome
Marcus CONRAD
Whitney HENRY
Thomas BRABLETZ
Scott AYTON
Pedro ANGELI
9:00 - 9:30
9:35 - 10:05
10:10 - 10:40
10:45 - 11:15
11:20 - 11:50
Posters Session 1
Lunch
11:55 - 13:30
Ferroptosis as the underlying mechanism in neurodegenerative disease
Ironing out the role of ether lipids in cancer: Effects on ferroptosis susceptibility and metastasis
EMT and cell plasticity in cancer - Driving force and therapeutic target
Ferroptosis as a mechanism of Alzheimer’s disease – from biochemistry to clinical trial
Deciphering Selenium Uptake: Implications for Ferroptosis Control
Scott J. DIXON
Andreas LINKERMANN
Toshitaka NAKAMURA
Tom VANDEN BERGHE
13:30 - 14:00
14:05 - 14:35
14:40 - 15:10
15:15 - 15:45
Posters Session 2
15:45 - 16:45
Ferroptosis regulation by the p53 pathway
Hyperglycemia-induced thioredoxin degradation accelerates ferroptotic cell death propagation in renal tubules
Phase separation of FSP1 triggers ferroptosis
How to stratify patients for ferroptosis intervention strategies?
Peter VANDENABEELE
Kivanç BIRSOY
Brent STOCKWELL
Jessalyn UBELLACKER
16:45 - 17:15
17:20 - 17:50
17:55 - 18:25
18:30 - 19:00
Interaction between ferroptotic dying cancer cells and the immune system
The role of mitochondrial redox homeostasis in physiology
Ferroptosis: links to diet and metabolism
Inducing lipid oxidation in lymph nodes to inhibit cancer metastasis
Poster Awards
19:00 - 19:15
